KFDA approves new statin preparation for lowering cholesterol

The Korea Food and Drug Administration said it approved AstraZeneca's Crestor (rosuvastatin) for treatment of hypercholestrolemia and mixed hyperlipidemia.

Crestor is in the class of drug called HMG-CoA reductase inhibitors, also known as statins. The lipid-lowering agent work by partially blocking the synthesis of cholesterol in the liver which leads to increased removal of cholesterol in t...